Tools
Tools
Collins, Kathryn C., Clark, Allan B. 
ORCID: https://orcid.org/0000-0003-2965-8941, Pomeroy, Valerie M. ORCID: https://orcid.org/0000-0003-4487-823X and Kennedy, Niamh C.
(2024)
The test-retest reliability of non-navigated transcranial magnetic stimulation (TMS) measures of corticospinal pathway excitability early after stroke.
Disability and Rehabilitation.
ISSN 0963-8288
Preview |
PDF (The test-retest reliability of non-navigated transcranial magnetic stimulation TMS measures of corticospinal pathway excitability early after stroke)
- Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (1MB) | Preview |
Abstract
Purpose: Motor evoked potential (MEP) characteristics are potential biomarkers of whether rehabilitation interventions drive motor recovery after stroke. The test-retest reliability of Transcranial Magnetic Stimulation (TMS) measurements in sub-acute stroke remains unclear. This study aims to determine the test-retest reliability of upper limb MEP measures elicited by non-neuronavigated transcranial magnetic stimulation in sub-acute-stroke. Methods: In two identical data collection sessions, 1–3 days apart, TMS measures assessed: motor threshold (MT), amplitude, latency (MEP-L), silent period (SP), recruitment curve slope in the biceps brachii (BB), extensor carpi radialis (ECR), and abductor pollicis brevis (APB) muscles of paretic and non-paretic upper limbs. Test-retest reliability was calculated using the intra-class correlation coefficient (ICC) and 95% confidence intervals (CI). Acceptable reliability was set at a lower 95% CI of 0.70 or above. The limits of agreement (LOA) and smallest detectable change (SDC) were calculated. Results: 30 participants with sub-acute stroke were included (av 36 days post stroke) reliability was variable between poor to good for the different MEP characteristics. The SDC values differed across muscles and MEP characteristics in both paretic and less paretic limbs. Conclusions: The present findings indicate there is limited evidence for acceptable test-retest reliability of non-navigated TMS outcomes when using the appropriate 95% CI for ICC, SDC and LOA values. Clinical Trial Registration: Current Controlled Trials: ISCRT 19090862, http://www.controlled-trials.com.
| Item Type: | Article |
|---|---|
| Additional Information: | Funding Information: Professor Pomeroy is grateful for the support of the National Institute for Health Research (NIHR) Brain Injury MedTech Co-operative based at Cambridge University Hospitals NHS Foundation Trust and University of Cambridge. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. Acknowledgements |
| Uncontrolled Keywords: | test-retest reliability,smallest detectable change,stroke,transcranial magnetic stimulation (tms),upper limb,rehabilitation ,/dk/atira/pure/subjectarea/asjc/2700/2742 |
| Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School Faculty of Medicine and Health Sciences > School of Health Sciences |
| UEA Research Groups: | Faculty of Medicine and Health Sciences > Research Groups > Norwich Clinical Trials Unit Faculty of Medicine and Health Sciences > Research Groups > Health Services and Primary Care Faculty of Medicine and Health Sciences > Research Groups > Epidemiology and Public Health Faculty of Medicine and Health Sciences > Research Centres > Population Health Faculty of Medicine and Health Sciences > Research Centres > Norwich Institute for Healthy Aging Faculty of Medicine and Health Sciences > Research Centres > Lifespan Health |
| Related URLs: | |
| Depositing User: | LivePure Connector |
| Date Deposited: | 05 Apr 2024 09:32 |
| Last Modified: | 07 May 2024 09:32 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/94831 |
| DOI: | 10.1080/09638288.2024.2337107 |
Downloads
Downloads per month over past year
Actions (login required)
 |
View Item |